期刊文献+

白喉毒素无毒突变体H21G蛋白的分泌性表达及纯化

Secretory expression and purification of avirulent diphtheria toxin mutant H21G protein
原文传递
导出
摘要 目的原核分泌性表达白喉毒素无毒突变体H21G蛋白并进行纯化,为下一步开发以重组H21G蛋白为基础的疫苗奠定基础。方法以p ET16a-H21G质粒为模板,PCR扩增H21G基因,亚克隆至p ET22b载体中,构建重组原核表达质粒p ET22b-H21G,转化感受态大肠埃希菌BL21(DE3),IPTG诱导重组H21G蛋白分泌性表达。重组蛋白经渗透压休克,DEAE Sepharose Fast Flow阴离子交换层析和Phenyl Sepharose 6FF(high sub)疏水层析纯化后,使用还原/非还原SDS-PAGE和HPLC法分析纯化蛋白的纯度,窄范围等电聚焦分析其等电点,MALDI-TOF质谱法分析其相对分子质量,N-末端测序法鉴定N-末端氨基酸序列。结果重组原核分泌性表达质粒p ET22b-H21G经双酶切(NcoⅠ和XhoⅠ)和测序证明构建正确;目标蛋白以可溶形式存在于宿主菌周质间隙,表达量为10%-15%;经纯化后,重组蛋白纯度达95%以上,等电点在4.55-6.20之间,相对分子质量和N-末端氨基酸序列均与白喉毒素相符合。结论成功分泌性表达并纯化了重组白喉毒素无毒突变体H21G蛋白,为下一步开发以重组H21G蛋白为基础的疫苗奠定了基础。 Objective To express avirulent diphtheria toxin(DT)mutant H21 G protein in a secretory form in prokaryotic cells, and lay a foundation of further development of H21G-based vaccine. Methods H21 G gene was amplified by PCR using plasmid p ET16a-H21 G as a template and subcloned to vector p ET22 b, and the constructed recombinant plasmid p ET22b-H21 G was transformed to competent E. coli BL21(DE3) for expression under induction of IPTG. The expressed protein was purified by osmotic shock treatment, DEAE Sepharose Fast Flow ion exchange chromatography and Phenyl Sepharose 6FF(high sub) hydrophobic chromatography, and determined for purity by reduced / non-reduced SDS-PAGE and HPLC, for isoelectric point by isoelectric focusing(IEF), for relative molecular mass by MALDI-TOF, and for Nterminal amino acid sequence by N-terminal sequencing. Results Restriction analysis(NcoⅠand XhoⅠ)and sequencing proved that recombinant secretory expression plasmid p ET22b-H21 G was constructed correctly. Expressed H21 G protein existed in periplasmic space of host cell in a soluble form, and contained about 10% -15% of total somatic protein.Purified H21 G protein reached a purity of more than 95%, of which the isoelectric point was 4. 55 - 6. 20, and the relative molecular mass and N-terminal amino acid sequence were consistent with those of DT. Conclusion Avirulent recombinant DT mutant H21 G protein was successfully expressed in a secretory form, which laid a foundation of further development of H21G-based vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2016年第12期1262-1266,共5页 Chinese Journal of Biologicals
关键词 白喉毒素 无毒突变体H21G 分泌性表达 纯化 Diphtheria toxin(DT) Avirulent mutant H21G Secretory expression Purification
  • 相关文献

参考文献3

二级参考文献31

  • 1徐斌,韩之波,杨萍,刘拥军,李妍涵,韩忠朝.茂原链轮丝菌转谷氨酰胺酶基因在大肠杆菌中高效表达[J].生物工程学报,2005,21(5):794-798. 被引量:9
  • 2黎名元,郭新民,乔传令.重组大肠杆菌高密度培养研究进展[J].微生物学杂志,2006,26(6):55-58. 被引量:4
  • 3肖洁,郭刚,邹全明.提高大肠杆菌分泌表达重组蛋白的研究进展[J].微生物学杂志,2007,27(2):73-77. 被引量:9
  • 4Liao Y D, Jeng J C, Wang C F, et al. Removal of N - terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase. Protein Science, 2004, 13 (7) : 1802.
  • 5Shokri A, Sanden A M, Larsson G. Cell and process design for targeting of recombinant protein into the culture medium of Escherichia coli. Appl Microbiol Biotechnol, 2003, 60 (8) : 654.
  • 6Mergulhao F J M, Summersb D K, Monteiro G A. Recombinant protein secretion in Escherichia coli. Biotechnology Advances, 2005, 23:177.
  • 7Choi J H, Jeong K J, Kim S C, et al. Efficient secretory production of alkaline phosphatase by high cell density culture of recombinant Escherichia coli using the Bacillussp Endoxylanase signal sequence. Appl Microbiol Biotechnol, 2000, 53 (6) : 640.
  • 8Jeong K J, Lee S Y. Excretory production of humanβ2 endorphin into euhure medium by using outermembrane protein Fas a fusion partner in reeombinant Escherichia coli. App 1 Environ Microbiol, 2002, 68 (10) : 4979.
  • 9Yamabhai M, Emrat S, Sukasem S, et al. Secretion of recombinant Bacillus hydrolytic enzymes using Escherichia cob expression systems. Journal of Biotechnology, 2008, 133 : 50.
  • 10Si Jae Park, Sang Yup Lee. Efficient recovery of secretory recombinant proteins from protease negative mutant Eseherichia colistrains. Biotechnology Techniques, 1998, 12( 11 ) : 815.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部